{"name":"Definium Therapeutics US, Inc.","slug":"definium-therapeutics-us-inc","ticker":"","exchange":"","domain":"definiumus.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MM120 (LSD D-Tartrate)","genericName":"MM120 (LSD D-Tartrate)","slug":"mm120-lsd-d-tartrate","indication":"Major depressive disorder (in development)","status":"phase_3"}]}],"pipeline":[{"name":"MM120 (LSD D-Tartrate)","genericName":"MM120 (LSD D-Tartrate)","slug":"mm120-lsd-d-tartrate","phase":"phase_3","mechanism":"MM120 is a formulated version of LSD (lysergic acid diethylamide) that acts as a serotonin 5-HT receptor agonist, particularly at 5-HT1A and 5-HT2A receptors, to modulate neural circuits involved in mood and perception.","indications":["Major depressive disorder (in development)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-19","type":"pipeline","source":"simplywall.st","summary":"Is It Too Late To Consider Definium Therapeutics (DFTX) After A 163% One Year Surge? - simplywall.st","headline":"Is It Too Late To Consider Definium Therapeutics (DFTX) After A 163% One Year Surge?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPLS15aGhrVms3Vk51SjlIMGd3SDgwTkhLdFJYT1E3RHFDaUR1Q08yV1psRC1wc1hJMU5fY2l1Z1pvaXhLLTZ4YjZ0OFFTQUtqaW1oMnB6blFuRVJYU1luRFVVaWFsMV9GNGNabGMwa2o1U0NzRGtOUmJKdXFEcnBZX1FTRk1HSXhkNUhWNjJTS1Y5cGhOODRJb1JBOUJBSUg2ZmdLclMzZU5GTmdPUGV5RXdBQllfSWFPeUY5dnlnVFBVRlREN2pLZlZEWQ?oc=5","date":"2026-03-09","type":"regulatory","source":"PR Newswire","summary":"CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions - PR Newswire","headline":"CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOQi02bFd5Q1lxVkVfQkFpbWJZamFaOFo3YVNKT09va3RQSEloa2ROSDg4eEVzOTNkcFltQ1piaW9UdFh4ZFFBYzlBOF9oY3N2Rld3ZG1QREF2TkJBeEZkdE12Ml9fTXUtRFR5SmhyaVdGYmNWYVBOYm1ySGZvbWlFQUhKclh2aUhkVzRIUkFjZGxMeWdFZG1fQzBCMXVwaDRlM1UyNGZVTjlYYlBHaUgyTktCWVE1S1ZXeDZyZGZlczh3VFBJNDlpenF5NHNKdw?oc=5","date":"2026-02-27","type":"trial","source":"Newswire Canada","summary":"Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments - Newswire Canada","headline":"Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOOHpaZm9zN0tMZlIzdWswM0duVUZHRjQxanJfOEl6SDJ0MEpacGptU0R2REJLOFVmRWNLaGdsX0E4SklCTGNTM29UaUM4bEhJYnEzVklFcGNaTDZXaWtVNGVCMTBVWC1Ub21xSWI1bmFGV1JKdUxhb1dNU1hUNlJZd0c4YUc2UzlMcmc0RFNINklrZnhDZFl2cDVwXzZjVFV2RGFpazRn?oc=5","date":"2026-02-26","type":"pipeline","source":"GuruFocus","summary":"Decoding Definium Therapeutics Inc (DFTX): A Strategic SWOT Insi - GuruFocus","headline":"Decoding Definium Therapeutics Inc (DFTX): A Strategic SWOT Insi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNRXFQSzVHZ0tjdGRNNXExQjdVRWJIOWswNUNPZWFvMHM3X3pSX01PM0VEVENBSkVSOC10aTlNc29oejZqcGZkcE1QbWtWeXZxYk1DZmVCSXRya1pjRnBMbVlvNDJobzFzVTdJMDV3Wm5kMFFFakRUZm9UQnAtcERVWWlmOF82RE11T2JQYWhzV1E1YkE?oc=5","date":"2026-02-05","type":"deal","source":"The Motley Fool","summary":"5 Psychedelic Stocks to Buy Now - The Motley Fool","headline":"5 Psychedelic Stocks to Buy Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPX3F6SXZiRWtWN0Vpd3pEYjlsWmRJcXFVTFptMFN2SDBLcmF4QUdJdjZVa0ZnZWdyTWxpZHNzMFc5X193eWppR1R5T2FaNUUwWUJIY1c4OTJXalJBQUhiVWhDM2ZNbXNtSTNJMzllUmM0bnFMbS1qMVZMdTFoS285bjZLLUhDcmFwVWpXNkU3eUs2SFJPcENDYXBVUW_SAVZBVV95cUxOSndlb0dtcUZ2SXpDazZSSlEtbUJ0a2pKeGRIVmVfdDdWSEppa3ZHOUhSYUcwTFBaN2RxdVVlaUN5c3NXRkhXVFdIdWZ6UmZUTXJQYktXZw?oc=5","date":"2026-02-03","type":"trial","source":"Law360","summary":"Pharma Co. Stole Secrets For LSD Medical Trials, Suit Says - Law360","headline":"Pharma Co. Stole Secrets For LSD Medical Trials, Suit Says - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPRFhvZEdwRkprb2NxT2lOekl6eWc2UVNLOTVpTnNZRlZObEx4X1JWVF9TVVdXbG4xZzU2UTJKM0tNMFpPRlY1VEVyd0djZmJlUkJoSjg0TjdRSHJUeEw2RUtLaE1zTG9WUWFjdDcyNHVNRTBGbVYtRWx5RlZHWVNSZWlOSF9lWlFRdW00Nno1a2l2RjhEc3FmUGtIRE5SR0JfZXJOM1pWVm9QTkVucTFZdExxdw?oc=5","date":"2026-02-02","type":"pipeline","source":"Reuters","summary":"LSD therapy biotech Definium sued for alleged trade secret theft - Reuters","headline":"LSD therapy biotech Definium sued for alleged trade secret theft","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1oZ1c5MWRCbzJfRFRNd2Z1WUlYR2FqdHZLT202ckI3QWhHQ3N4anlqdklpNFJ3NmUwdGhXVXd3UzNtV2ZBTHkyOFgta0c4aWx2em5aNUU3dXYzaDNa?oc=5","date":"2026-01-26","type":"pipeline","source":"TradingView","summary":"DFTX Stock Price and Chart — NASDAQ:DFTX - TradingView","headline":"DFTX Stock Price and Chart — NASDAQ:DFTX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNRDFOVWNXZVU1RW9DUUZST19uVFBMS0ExY2g4Wkc4MU9qeUNVeUE5dkUwbGpXZ1NsWUpJTEtDSzJCNFk0ZkVBRmlKUnVpSTlHSEUxMldTUVRMd0JUQ0RVSkxudzVZaHVBOFJxUWVZaVZ3Tndvc3FrMlFNS3JmMzhZeHVTUjBDdm9WMUl3Q0x4ejhZVjRlbk5pUHpYY19OZXA1cTdkRlNZbE1wTlRHNXc?oc=5","date":"2026-01-20","type":"pipeline","source":"Fierce Pharma","summary":"Definium defines mental health applications for LSD in new awareness campaign - Fierce Pharma","headline":"Definium defines mental health applications for LSD in new awareness campaign","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxQdy1Rd2RPRkhQenhpRV9DZ0FuYW9HNFRmWVpEMEpGWk9uUVpNMW8zY01MOFpRUUhyUHdPMlpzT2lDTWVJVjBvbnF5NF9kTTdRSU93bnRjdmM1a095MmJ4LVFQYVpXZVZUN1ZCNTdRLWw2aWJrNHhYZU0wZ2VmX2o5dzFVY1ROanJBNXh0Y2tCWWZjNXdFc3pGUTZ0SDh4ZXQ0SkRIOF9VOURPWEthWExQcWNRWkw0OGNON3NBQUJxcHBJMDBTcVdzVVRsZkw1ZUkxaGFWbkV0T2d0VjJxUHpaNmdDRm5pRGw2X2hEQ2dNVEpyNFdwdVRpZ09GajU4cEVQZmhJMUMybTBneWI2c2hXWVo3b1A3a2pJS1Y3ODl5c3B4cDlVazV5bDl2X0ZQRkh4?oc=5","date":"2026-01-20","type":"pipeline","source":"Business Wire","summary":"Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care - Business Wire","headline":"Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lyse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNMi12TVpDMWYzeGZCeVRWTVBLRkgzY1luaHFibWhPc0pNLWN3STNZNGEzTDZmaUxYZGRKWjExcTdNMFh0UTVzY21Bb2ZWdm5QSlZzcHcwbFE1NWhWN1N0SjAzLTBSZEU0ZEtCb2FSTlZONTJnQVpSWlBOVkF5Y1VBdFF4ZFlNODNGcWFESGxlUlk?oc=5","date":"2026-01-19","type":"pipeline","source":"Yahoo Finance","summary":"A Look At Definium Therapeutics (DFTX) Valuation After Recent Double Digit Share Price Returns - Yahoo Finance","headline":"A Look At Definium Therapeutics (DFTX) Valuation After Recent Double Digit Share Price Returns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQUmRjMXU0WlNTd1Q4VmRiMnQ4Tmt1RkVualVOU2tIS2RzbjlDTEo2R3J4UXU4ZllBT2EwcW9sMi0wbkFGUnphaTEyWVBmVU5NS0RacnhzeWZsSFNCdjJPd2Y2NEMwd21ZM1N4UnlCTlNyS282RUlDRzlIT1ViWVo1U0tHUmIxOGhXWnBFSU45NGtzYV84TXJ2SjU1Si16VVZud3VSR2RDbmVHa2FPNy1WWDBGeGhnT0pjMm9BcDltVnFRS3NMSklNVkpLMjljbEF3Z0tJ?oc=5","date":"2026-01-19","type":"trial","source":"Endpoints News","summary":"A Psychedelic Renaissance: How Definium Therapeutics is Changing How We Think about LSD and Treat Mental Health - Endpoints News","headline":"A Psychedelic Renaissance: How Definium Therapeutics is Changing How We Think about LSD and Treat Mental Health","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}